A RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ARHALOFENATE FOR PREVENTING FLARES AND REDUCING SERUM URIC ACID IN GOUT PATIENTS
- Registry ID
- CB102-21425
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- CYMABAY THERAPEUTICS INC
- Start date
- 2014-04-10
- Last update
- 2014-03-03
Conditions
View on source registry